PL186618B1 - Izotoniczna emulsja lipidowa do podawania pozajelitowego i jej zastosowanie - Google Patents

Izotoniczna emulsja lipidowa do podawania pozajelitowego i jej zastosowanie

Info

Publication number
PL186618B1
PL186618B1 PL96326929A PL32692996A PL186618B1 PL 186618 B1 PL186618 B1 PL 186618B1 PL 96326929 A PL96326929 A PL 96326929A PL 32692996 A PL32692996 A PL 32692996A PL 186618 B1 PL186618 B1 PL 186618B1
Authority
PL
Poland
Prior art keywords
fish
oil
triglycerides
lipid
fatty acids
Prior art date
Application number
PL96326929A
Other languages
English (en)
Polish (pl)
Other versions
PL326929A1 (en
Inventor
German Pscherer
Marco Junginger
Jörg Nehne
Yvon A. Carpentier
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7778601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL186618(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of PL326929A1 publication Critical patent/PL326929A1/xx
Publication of PL186618B1 publication Critical patent/PL186618B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL96326929A 1995-11-28 1996-11-23 Izotoniczna emulsja lipidowa do podawania pozajelitowego i jej zastosowanie PL186618B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19544310 1995-11-28
PCT/EP1996/005184 WO1997019683A1 (en) 1995-11-28 1996-11-23 Hydrolysis-optimized lipid emulsions and use thereof

Publications (2)

Publication Number Publication Date
PL326929A1 PL326929A1 (en) 1998-11-09
PL186618B1 true PL186618B1 (pl) 2004-02-27

Family

ID=7778601

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326929A PL186618B1 (pl) 1995-11-28 1996-11-23 Izotoniczna emulsja lipidowa do podawania pozajelitowego i jej zastosowanie

Country Status (15)

Country Link
US (1) US6008248A (enExample)
EP (1) EP0863754B2 (enExample)
JP (1) JP4165904B2 (enExample)
CN (1) CN1259908C (enExample)
AT (1) ATE230262T1 (enExample)
AU (1) AU701736B2 (enExample)
BR (1) BR9611826A (enExample)
CA (1) CA2236422C (enExample)
CZ (1) CZ161898A3 (enExample)
DE (2) DE69625616T3 (enExample)
ES (1) ES2189891T5 (enExample)
MX (1) MX9804127A (enExample)
NZ (1) NZ322927A (enExample)
PL (1) PL186618B1 (enExample)
WO (1) WO1997019683A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
US6946488B2 (en) * 2000-05-01 2005-09-20 The Iams Company Pet food composition for reducing inflammatory response in cats
EP1539104A4 (en) * 2000-12-29 2005-06-15 Univ Columbia USE OF IV EMULSIONS OF DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS
EP1900364B1 (en) * 2001-04-18 2013-09-25 ProMetic BioSciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
EP1279400A1 (en) * 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
AU2002350353A1 (en) * 2001-12-27 2003-07-15 Genesis Group Inc. Seal oil based lipid emulsions and uses thereof
CA2496923A1 (en) * 2002-08-29 2004-03-11 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
EP2560633B8 (en) 2010-04-23 2020-08-12 The Government of the United States, as represented by The Secretary of the Army Intravenous omega-3 fatty acid compositions & method of use
CN106241871A (zh) * 2016-07-15 2016-12-21 攀钢集团攀枝花钢铁研究院有限公司 高浓度钒液酸性铵盐沉钒方法
CN117918525A (zh) 2017-08-10 2024-04-26 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
CN108498562B (zh) * 2018-04-08 2021-03-16 北京壹诺药业有限公司 具有抗疲劳抗肿瘤增强免疫的油脂乳状液及其应用
US20220040141A1 (en) * 2018-10-01 2022-02-10 Blue Harvest, Llc Ultrapure phenol compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) * 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5574065A (en) † 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response

Also Published As

Publication number Publication date
AU701736B2 (en) 1999-02-04
CN1259908C (zh) 2006-06-21
ES2189891T3 (es) 2003-07-16
PL326929A1 (en) 1998-11-09
ATE230262T1 (de) 2003-01-15
DE69625616T2 (de) 2003-11-06
EP0863754B2 (en) 2009-12-30
JP4165904B2 (ja) 2008-10-15
BR9611826A (pt) 1999-07-13
DE69625616D1 (de) 2003-02-06
DE69625616T3 (de) 2010-07-08
NZ322927A (en) 1999-06-29
EP0863754B1 (en) 2003-01-02
EP0863754A1 (en) 1998-09-16
CN1202823A (zh) 1998-12-23
CZ161898A3 (cs) 1998-11-11
US6008248A (en) 1999-12-28
CA2236422C (en) 2002-11-19
AU7697296A (en) 1997-06-19
MX9804127A (es) 1998-12-31
DE19648566A1 (de) 1997-06-05
CA2236422A1 (en) 1997-06-05
JP2000500769A (ja) 2000-01-25
ES2189891T5 (es) 2010-04-27
WO1997019683A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
US7560486B2 (en) Composition and method for modifying the fatty acid composition of cell membranes of organs and tissues
PL186618B1 (pl) Izotoniczna emulsja lipidowa do podawania pozajelitowego i jej zastosowanie
US8536232B2 (en) Omega-3 diglyceride emulsions
AU613420B2 (en) Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
KR20110130465A (ko) 오메가-3 풍부화된 비경구 영양 수중-어유 에멀전
EP0767666B1 (en) Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
JP3132085B2 (ja) 脂肪乳剤
US5587366A (en) Compositions useful in prophylaxis and therapy of endotoxin related conditions
CA2050586A1 (en) Pharmaceutical lipid composition for parenteral nutrition
HUP9903426A2 (hu) Optimalizált hidrolízisű lipid emulziók és ezek gyógyszerként történő alkalmazása
JP2837922B2 (ja) ポリプレノイド化合物を含有する脂肪乳剤

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20051123